Breaking News Instant updates and real-time market news.

GILD

Gilead

$60.01 /

-0.14 (-0.23%)

08:10
01/06/21
01/06
08:10
01/06/21
08:10

Kite, Oxford BioTherapeutics enter research collaboration

Kite, a Gilead company, and Oxford BioTherapeutics, a clinical stage oncology company with a pipeline of immuno-oncology, or IO, and antibody-drug conjugate, or ADC-based therapies, announced that the companies have entered into a research collaboration to evaluate five novel targets for a number of hematologic and solid tumor indications. Through this collaboration, OBT will validate five novel oncology drug targets, previously identified using OBT's OGAP discovery platform, and generate antibodies against these targets. Kite and Gilead will have the exclusive right to develop and commercialize therapies based on these targets or antibodies. Under the terms of the agreement, OBT will receive an upfront payment and will be eligible to receive additional payments based on achievement of certain discovery, clinical and regulatory milestones, as well as royalties on future potential sales.

GILD Gilead
$60.01 /

-0.14 (-0.23%)

01/04/21 Guggenheim
Gilead upgraded to Buy from Neutral at Guggenheim
12/22/20 Citi
Gilead price target lowered to $72 from $75 at Citi
12/18/20 Truist
Gilead price target lowered to $62 from $67 at Truist
12/17/20 Maxim
Galapagos price target lowered to $140 from $170 at Maxim

TODAY'S FREE FLY STORIES

Upgrade
Arjo upgraded to Buy from Hold at SEB Equities » 05:28
02/25/21
02/25
05:28
02/25/21
05:28
ARRJF

Arjo

$0.00 /

+ (+0.00%)

SEB Equities analyst Carl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARRJF Arjo
$0.00 /

+ (+0.00%)

01/27/21 SEB Equities
Arjo downgraded to Hold from Buy at SEB Equities
01/25/21 Pareto
Arjo downgraded to Hold from Buy at Pareto
01/20/21 Nordea
Arjo downgraded to Sell from Hold at Nordea
Earnings
Teekay LNG reports Q4 adjusted EPS 61c, consensus 61c » 05:27
02/25/21
02/25
05:27
02/25/21
05:27
TGP

Teekay LNG

$13.76 /

+0.445 (+3.34%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGP Teekay LNG
$13.76 /

+0.445 (+3.34%)

01/29/21 Jefferies
Teekay LNG price target raised to $14 from $12 at Jefferies
09/16/20 B. Riley FBR
Teekay LNG initiated with a Buy, $13 price target at B. Riley FBR
09/15/20 B. Riley FBR
Teekay LNG initiated with a Buy at B. Riley FBR
TGP Teekay LNG
$13.76 /

+0.445 (+3.34%)

Downgrade
Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley » 05:27
02/25/21
02/25
05:27
02/25/21
05:27
EPZM

Epizyme

$10.21 /

-0.19 (-1.83%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EPZM Epizyme
$10.21 /

-0.19 (-1.83%)

EPZM Epizyme
$10.21 /

-0.19 (-1.83%)

02/24/21 Citi
Epizyme price target lowered to $27 from $35 at Citi
12/21/20 Jefferies
Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view
12/21/20 Jefferies
Epizyme downgraded to Hold from Buy at Jefferies
11/09/20 Barclays
Epizyme price target lowered to $18 from $33 at Barclays
EPZM Epizyme
$10.21 /

-0.19 (-1.83%)

EPZM Epizyme
$10.21 /

-0.19 (-1.83%)

EPZM Epizyme
$10.21 /

-0.19 (-1.83%)

Upgrade
CME Group upgraded to Overweight from Equal Weight at Wells Fargo » 05:27
02/25/21
02/25
05:27
02/25/21
05:27
CME

CME Group

$200.75 /

+2.15 (+1.08%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CME CME Group
$200.75 /

+2.15 (+1.08%)

CME CME Group
$200.75 /

+2.15 (+1.08%)

02/11/21 Citi
CME Group price target lowered to $207 from $210 at Citi
01/15/21 Oppenheimer
CME Group downgraded to Perform on valuation at Oppenheimer
01/15/21 Oppenheimer
CME Group downgraded to Perform from Outperform at Oppenheimer
01/12/21 Barclays
CME Group price target raised to $215 from $200 at Barclays
CME CME Group
$200.75 /

+2.15 (+1.08%)

CME CME Group
$200.75 /

+2.15 (+1.08%)

CME CME Group
$200.75 /

+2.15 (+1.08%)

CME CME Group
$200.75 /

+2.15 (+1.08%)

Upgrade
LSL Property Services upgraded to Add from Hold at Peel Hunt » 05:26
02/25/21
02/25
05:26
02/25/21
05:26
LSLPF

LSL Property Services

$0.00 /

+ (+0.00%)

Peel Hunt analyst Sam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Faurecia SA initiated with a Neutral at Citi » 05:25
02/25/21
02/25
05:25
02/25/21
05:25
FURCF

Faurecia SA

$0.00 /

+ (+0.00%)

Citi analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FURCF Faurecia SA
$0.00 /

+ (+0.00%)

11/02/20 RBC Capital
Faurecia SA price target raised to EUR 36 from EUR 35 at RBC Capital
09/30/20 Morgan Stanley
Faurecia SA price target lowered to EUR 34 from EUR 36 at Morgan Stanley
09/21/20 Oddo BHF
Faurecia SA upgraded to Buy from Neutral at Oddo BHF
09/10/20 BofA
Faurecia SA upgraded to Buy from Neutral at BofA
Downgrade
Valeo downgraded to Sell from Neutral at Citi » 05:24
02/25/21
02/25
05:24
02/25/21
05:24
VLEEY

Valeo

$0.00 /

+ (+0.00%)

Citi analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLEEY Valeo
$0.00 /

+ (+0.00%)

02/22/21 Berenberg
Valeo price target raised to EUR 39 from EUR 37 at Berenberg
02/19/21 Societe Generale
Valeo price target raised to EUR 35 from EUR 28 at Societe Generale
02/19/21 Deutsche Bank
Valeo price target raised to EUR 28 from EUR 25 at Deutsche Bank
01/27/21 Berenberg
Valeo price target raised to EUR 37 from EUR 34 at Berenberg
Downgrade
Taiheiyo Cement downgraded to Neutral from Buy at Mizuho » 05:22
02/25/21
02/25
05:22
02/25/21
05:22
THYCY

Taiheiyo Cement

$0.00 /

+ (+0.00%)

Mizuho analyst Hiroshi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Nike upgraded to Buy from Hold at HSBC » 05:22
02/25/21
02/25
05:22
02/25/21
05:22
NKE

Nike

$135.79 /

-0.35 (-0.26%)

HSBC analyst Erwan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$135.79 /

-0.35 (-0.26%)

NKE Nike
$135.79 /

-0.35 (-0.26%)

02/05/21 Citi
Foot Locker upgraded to Buy from Neutral at Citi
02/05/21 Citi
Citi sees 'many reasons' for why Nike should acquire Foot Locker
02/03/21 Jefferies
Under Armour price target raised to $25 from $23 at Jefferies
01/25/21 KeyBanc
Nike price target raised to $180 from $174 at KeyBanc
NKE Nike
$135.79 /

-0.35 (-0.26%)

NKE Nike
$135.79 /

-0.35 (-0.26%)

NKE Nike
$135.79 /

-0.35 (-0.26%)

NKE Nike
$135.79 /

-0.35 (-0.26%)

Earnings
NetEase reports Q4 EPS 36c, consensus 45c » 05:21
02/25/21
02/25
05:21
02/25/21
05:21
NTES

NetEase

$117.62 /

-2.69 (-2.24%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTES NetEase
$117.62 /

-2.69 (-2.24%)

NTES NetEase
$117.62 /

-2.69 (-2.24%)

02/16/21 Barclays
NetEase price target raised to $155 from $110 at Barclays
12/31/20
NetEase initiated with an Outperform at Industrial Securities
11/02/20 Goldman Sachs
NetEase price target raised to $107 from $104 at Goldman Sachs
10/07/20 Citi
NetEase price target lowered to $106 from $112.60 at Citi
NTES NetEase
$117.62 /

-2.69 (-2.24%)

NTES NetEase
$117.62 /

-2.69 (-2.24%)

NTES NetEase
$117.62 /

-2.69 (-2.24%)

NTES NetEase
$117.62 /

-2.69 (-2.24%)

Upgrade
Dixons Carphone upgraded to Buy from Hold at Investec » 05:21
02/25/21
02/25
05:21
02/25/21
05:21
DSITF

Dixons Carphone

$0.00 /

+ (+0.00%)

Investec analyst Benedict…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DSITF Dixons Carphone
$0.00 /

+ (+0.00%)

01/18/21 RBC Capital
Dixons Carphone upgraded to Outperform from Sector Perform at RBC Capital
12/17/20 Barclays
Dixons Carphone price target raised to 145 GBp from 120 GBp at Barclays
10/16/20 RBC Capital
Dixons Carphone upgraded to Sector Perform from Underperform at RBC Capital
09/04/20 Exane BNP Paribas
Dixons Carphone downgraded to Neutral from Outperform at Exane BNP Paribas
Upgrade
NXP Semiconductors upgraded to Buy from Neutral at Citi » 05:19
02/25/21
02/25
05:19
02/25/21
05:19
NXPI

NXP Semiconductors

$186.31 /

+5.27 (+2.91%)

Citi analyst Christopher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

02/17/21 Wells Fargo
Wells says NXP plants in Austin make up less than 30% of production sq. footage
02/03/21
Fly Intel: Top five analyst upgrades
02/03/21
NXP Semiconductors price target raised to $223 from $200 at Needham
02/03/21 Credit Suisse
NXP Semiconductors price target raised to $215 from $175 at Credit Suisse
NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

Earnings
Youdao reports Q4 EPS (58c), consensus (70c) » 05:18
02/25/21
02/25
05:18
02/25/21
05:18
DAO

Youdao

$30.20 /

+0.695 (+2.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DAO Youdao
$30.20 /

+0.695 (+2.36%)

DAO Youdao
$30.20 /

+0.695 (+2.36%)

01/04/21 Macquarie
Youdao initiated with an Outperform at Macquarie
01/04/21 Macquarie
Youdao initiated with an Outperform at Macquarie
10/22/20 Nomura
Nomura downgrades GSX Techedu to Reduce, cuts target to 'Street-low' $38
09/02/20
Fly Intel: Top five analyst downgrades
DAO Youdao
$30.20 /

+0.695 (+2.36%)

  • 11
    Feb
DAO Youdao
$30.20 /

+0.695 (+2.36%)

Upgrade
Suzuki Motor upgraded to Outperform from Neutral at Daiwa » 05:18
02/25/21
02/25
05:18
02/25/21
05:18
SZKMY

Suzuki Motor

$0.00 /

+ (+0.00%)

Daiwa analyst Eiji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SZKMY Suzuki Motor
$0.00 /

+ (+0.00%)

10/03/20 Goldman Sachs
Suzuki Motor upgraded to Conviction Buy from Buy at Goldman Sachs
08/28/20 Daiwa
Suzuki Motor downgraded to Neutral from Outperform at Daiwa
03/17/20 Nomura Instinet
Suzuki Motor upgraded to Neutral from Reduce at Nomura Instinet
Downgrade
Solon Eiendom downgraded to Hold from Buy at DNB Markets » 05:17
02/25/21
02/25
05:17
02/25/21
05:17
BNRPF

Solon Eiendom

$0.00 /

+ (+0.00%)

DNB Markets analyst Simen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Scor downgraded to Hold from Buy at Commerzbank » 05:16
02/25/21
02/25
05:16
02/25/21
05:16
SCRYY

Scor

$0.00 /

+ (+0.00%)

Commerzbank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCRYY Scor
$0.00 /

+ (+0.00%)

01/12/21 Berenberg
Scor price target raised to EUR 36 from EUR 32 at Berenberg
12/17/20 Bryan Garnier
Scor downgraded to Buy from Conviction Buy at Bryan Garnier
11/30/20 Morgan Stanley
Scor price target raised to EUR 36 from EUR 33 at Morgan Stanley
11/18/20 RBC Capital
Scor upgraded to Outperform from Sector Perform at RBC Capital
Upgrade
GB Group upgraded to Buy from Hold at Stifel » 05:15
02/25/21
02/25
05:15
02/25/21
05:15
GBGPF

GB Group

$0.00 /

+ (+0.00%)

Stifel analyst Bridie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBGPF GB Group
$0.00 /

+ (+0.00%)

10/29/20 Panmure Gordon
GB Group upgraded to Buy from Hold at Panmure Gordon
10/20/20 Berenberg
GB Group upgraded to Buy from Hold at Berenberg
10/12/20 Citi
Citi opens 'positive catalyst watch' on GB Group
10/07/20 Canaccord
GB Group upgraded to Buy from Hold at Canaccord
Upgrade
JCR Pharmaceuticals upgraded to Outperform from Neutral at Credit Suisse » 05:14
02/25/21
02/25
05:14
02/25/21
05:14
JCRRF

JCR Pharmaceuticals

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
TD Holdings subsidiary granted Dangerous Chemicals Business License » 05:14
02/25/21
02/25
05:14
02/25/21
05:14
GLG

TD Holdings

$2.44 /

+0.14 (+6.09%)

TD Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLG TD Holdings
$2.44 /

+0.14 (+6.09%)

Upgrade
Vestas upgraded to Buy from Neutral at UBS » 05:13
02/25/21
02/25
05:13
02/25/21
05:13
VWDRY

Vestas

$0.00 /

+ (+0.00%)

UBS analyst Supriya…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VWDRY Vestas
$0.00 /

+ (+0.00%)

02/11/21 Deutsche Bank
Vestas price target lowered to DKK 1,460 from DKK 1,500 at Deutsche Bank
02/08/21 Deutsche Bank
Vestas price target lowered to DKK 1,500 from DKK 1,630 at Deutsche Bank
02/08/21 SEB Equities
Vestas downgraded to Hold from Buy at SEB Equities
01/15/21 Morgan Stanley
Vestas price target raised to DKK 1,099 from DKK 1,066 at Morgan Stanley
Hot Stocks
Xencor, UCLA TDG collaborate to develop XmAb therapeutics » 05:12
02/25/21
02/25
05:12
02/25/21
05:12
XNCR

Xencor

$48.58 /

+0.09 (+0.19%)

Xencor and UCLA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XNCR Xencor
$48.58 /

+0.09 (+0.19%)

XNCR Xencor
$48.58 /

+0.09 (+0.19%)

02/24/21 Piper Sandler
Xencor remains a top pick for 2021 at Piper Sandler
02/24/21 RBC Capital
Xencor price target raised to $59 from $48 at RBC Capital
02/24/21 Raymond James
Xencor upgraded to Outperform from Market Perform at Raymond James
02/24/21 Barclays
Xencor price target raised to $34 from $31 at Barclays
XNCR Xencor
$48.58 /

+0.09 (+0.19%)

Upgrade
AstraZeneca upgraded to Buy from Neutral at UBS » 05:11
02/25/21
02/25
05:11
02/25/21
05:11
AZN

AstraZeneca

$49.17 /

+0.81 (+1.67%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
01/22/21 Barclays
AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays
01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

General news
FX Action: USD-CAD has posted a three-year low » 05:10
02/25/21
02/25
05:10
02/25/21
05:10

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Vipshop reports Q4 EPS 54c, consensus 49c » 05:07
02/25/21
02/25
05:07
02/25/21
05:07
VIPS

Vipshop

$36.39 /

-0.07 (-0.19%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

02/01/21 Morgan Stanley
Vipshop user engagement to underpin 'solid' user growth, says Morgan Stanley
02/01/21 Morgan Stanley
Vipshop upgraded to Overweight from Underweight at Morgan Stanley
01/26/21 KeyBanc
Vipshop downgraded to Sector Weight at KeyBanc on lack of drivers
01/26/21 KeyBanc
Vipshop downgraded to Sector Weight from Overweight at KeyBanc
VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

Recommendations
Elastic price target raised to $185 from $175 at Jefferies » 05:05
02/25/21
02/25
05:05
02/25/21
05:05
ESTC

Elastic

$157.48 /

+4.36 (+2.85%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$157.48 /

+4.36 (+2.85%)

ESTC Elastic
$157.48 /

+4.36 (+2.85%)

02/19/21 RBC Capital
Elastic price target raised to $175 from $155 at RBC Capital
01/21/21 Goldman Sachs
Elastic initiated with a Neutral at Goldman Sachs
01/19/21 Truist
Elastic initiated with a Buy at Truist
01/15/21 Stifel
Elastic upgraded to Buy after licensing changes at Stifel
ESTC Elastic
$157.48 /

+4.36 (+2.85%)

ESTC Elastic
$157.48 /

+4.36 (+2.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.